FDA
US Markets

US FDA approves Verona Pharma’s inhaled COPD therapy

/

(Reuters) -The U.S. Food and Drug Administration has approved a treatment from Verona Pharma (NASDAQ: VRNA) for a chronic lung […]

US FDA approves Verona Pharma’s inhaled COPD therapy Read More »